Hemisphere Energy Corporation (HME)
TSX Venture Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 2.240 |
|---|---|
| 52-week range | 1.830 – 3.080 |
| Return, 1 month / 3 months | +0.9% / −16.4% |
| Return, 1 year / 3 years | +15.5% / +116.2% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 34.4% |
| Worst drawdown (1 year) | -24.9% |
| Average daily value traded | 0.42M CAD |
| Dividend yield | 7.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hemisphere Energy Corporation is a Canadian oil and gas producer focused on conventional heavy oil. The company develops and operates properties in Alberta, where it uses waterflood and polymer flood techniques to increase recovery from its oil pools. Its customers are the buyers of crude oil, and its operations centre on producing and marketing heavy oil from its core assets in the province. Hemisphere Energy is based in Vancouver, British Columbia.
Hemisphere Energy Corporation trades under the code HME on the TSX Venture Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hemisphere Energy Corporation (HME) trades on the TSX Venture Exchange in Canada. It last closed at CAD 2.240 on 23 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 191 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.5% and over the last three months it fell 16.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -7.8% | ||
| From 52-week high | -26.6% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -16.4% | ||
| 6-month return | -19.2% | ||
| 12-month return, skipping the last month | 14.5% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.9% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 0.42M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 7.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | +0.9% |
| 3 months | −16.4% |
| 6 months | −19.2% |
| 1 year | +15.5% |
| 3 years | +116.2% |
| 5 years | +258.9% |
Signals
| 50-day / 200-day average | 2.325 / 2.429 |
|---|---|
| Golden / death cross (60 days) | Death, 14 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.062 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | CAD 0.0250 |
| 12 Jun 2026 | CAD 0.0250 |
| 14 May 2026 | CAD 0.0300 |
| 15 Apr 2026 | CAD 0.0300 |
| 12 Feb 2026 | CAD 0.0250 |
| 9 Dec 2025 | CAD 0.0250 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.